The global nanopharmaceuticals market size was valued at USD 29.4 billion in 2018 and is anticipated to grow at a CAGR of 20.3% during the forecast period. Nanopharmaceuticals comprised of active molecules or biological substances that are prepared primarily for improving the drug therapies through attenuating toxicity profiles and safety concerns, or in vivo imaging.

Key Developments in Nanopharmaceuticals Market:
• In October 2019, The Union Minister of India for Science & Technology, Earth Sciences and Health & Family Welfare launched the guidelines for evaluation of nanopharmaceuticals in India.
• In October 2019, The Government of India introduced new regulatory guidelines to enhance and indorse the demand for nano-pharmaceuticals in the country.
• According to the European Union, the government strategies to increase the production of nanopharmaceuticals from pre-clinical laboratory and introduced GMP quality for clinical testing to improve manufacturing capacity and supply infrastructure.